Apparent effect of rabbit endogenous lentivirus type K acquisition on retrovirus restriction by lagomorph Trim5αs

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1626, 2013, Pages

  Yap, Melvyn W ^a   Stoye, Jonathan P ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Endogenous retroviruses; Evolution; Restriction

Indexed keywords

EVOLUTIONARY BIOLOGY; HYPOTHESIS TESTING; LAGOMORPH; NATURAL SELECTION; PRIMATE; VIRUS;

CERCOPITHECIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LAGOMORPHA; LENTIVIRUS; MIRIDAE; OCHOTONIDAE; ORYCTOLAGUS CUNICULUS; PLATYRRHINI; SYLVILAGUS;

CARRIER PROTEIN; VIRUS DNA;

ANIMAL; CELL LINE; DNA SEQUENCE; ENDOGENOUS RETROVIRUS; GENETICS; LAGOMORPH; LENTIVIRINAE; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; VIROLOGY;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; DNA, VIRAL; ENDOGENOUS RETROVIRUSES; EVOLUTION, MOLECULAR; LAGOMORPHA; LENTIVIRUS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84898675752     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0498     Document Type: Article

References (60)

1. Stoye JP. 2012 Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat. Rev. Microbiol. 10, 395-406. (doi:10.1038/ nrmicro2783)
2. Feschotte C, Gilbert C. 2012 Endogenous viruses: insights into viral evolution and impact on host biology. Nat. Rev. Genet. 13, 283-296. (doi:10. 1038/nrg3199)
3. Goodchild NL, Wilkinson DA, Mager DL. 1993 Recent evolutionary expansion of a subfamily of RTVL-H human endogenous retrovirus-like elements. Virology 196, 778-788. (doi:10.1006/viro. 1993.1535)
4. Emerman M, Malik HS. 2010 Paleovirology: modern consequences of ancient viruses. PLoS Biol. 8, e1000301. (doi:10.1371/journal.pbio.1000301)
5. Patel MR, Emerman M, Malik HS. 2011 Paleovirology: ghosts and gifts of viruses past. Curr. Opin. Virol. 1, 304-309. (doi:10.1016/j.coviro. 2011.06.007)
6. Katzourakis A, Tristem M, Pybus OG, Gifford RJ. 2007 Discovery and analysis of the first endogenous lentivirus. Proc. Natl Acad. Sci. USA 104, 6261-6265. (doi:10.1073/pnas.0700471104)
7. Goldstone DC, Yap MW, Robertson LE, Haire LF, Taylor WR, Katzourakis A, Stoye JP, Taylor IA. 2010 Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface. Cell Host Microbe 8, 248-259. (doi:10.1016/j.chom. 2010.08.006)
8. Keckesova Z, Ylinen LM, Towers GJ, Gifford RJ, Katzourakis A. 2009 Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses. Virology 384, 7-11. (doi:10.1016/j.virol.2008.10.045)
9. van der Loo W, Abrantes J, Esteves PJ. 2009 Sharing of endogenous lentiviral gene fragments among leporid lineages separated for more than 12 million years. J. Virol. 83, 2386-2388. (doi:10.1128/JVI. 01116-08)
10. Malim MH, Bieniasz PD. 2012 HIV restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2, a006940. (doi:10.1101/ cshperspect.a006940)
11. Best S, Le Tissier P, Towers G, Stoye JP. 1996 Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382, 826-829. (doi:10.1038/ 382826a0)
12. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissler P, Sodroski J. 2004 The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853. (doi:10. 1038/nature02343)
13. Ylinen LMJ, Keckesova Z, Webb BLJ, Gifford RJM, Smith TPL, Towers GJ. 2006 Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J. Virol. 80, 7332-7338. (doi:10.1128/JVI.00516-06)
14. Si Z et al. 2006 Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl Acad. Sci. USA 103, 7454-7459. (doi:10.1073/pnas.0600771103)
15. Schaller T, Hué S, Towers GJ. 2007 An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J. Virol. 81, 11713-11721. (doi:10.1128/JVI.01468-07)
16. Boudinot P, van der Aa LM, Jouneau L, Du Pasquier L, Pontarotti P, Briolat V, Benmansour A, Levraud J-P. 2011 Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish. PLoS ONE 6, e22022. (doi:10.1371/journal.pone.0022022)
17. Nisole S, Stoye JP, Saïb A. 2005 Trim family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3, 799-808. (doi:10.1038/ nrmicro1248)
18. Han K, Lou DI, Sawyer SL. 2011 Identification of a genomic reservoir for new TRIM genes in primate genomes. PLoS Genet. 7, e1002388. (doi:10.1371/ journal.pgen.1002388)
19. Short KM, Cox TC. 2006 Sub-classification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding. J. Biol. Chem. 281, 8970-8980. (doi:10.1074/jbc.M512755200)
20. Sardiello M, Cairo S, Fontanella B, Ballabio A, Meroni G. 2008 Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol. Biol. 8, 225. (doi:10.1186/1471-2148-8-225)
21. Keckesova Z, Ylinen LMJ, Towers GJ. 2004 The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl Acad. Sci. USA 101, 10780-10785. (doi:10.1073/pnas.0402474101)
22. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD. 2004 Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α. Proc. Natl Acad. Sci. USA 101, 10774-10779. (doi:10.1073/pnas.0402361101)
23. Yap MW, Nisole S, Lynch C, Stoye JP. 2004 TRIM5α protein restricts both HIV-1 and murine leukemia virus. Proc. Natl Acad. Sci. USA 101, 10786-10791. (doi:10.1073/pnas.0402876101)
24. Yap MW, Lindemann D, Stanke N, Reh J, Westphal D, Hanenberg H, Ohkural S, Stoye JP. 2008 Restriction of foamy viruses by primate TRIM5αlpha. J. Virol. 82, 5429-5439. (doi:10.1128/JVI.02462-07)
25. Diehl WE, Stansell E, Kaiser SM, Emerman M, Hunter E. 2008 Identification of post-entry restrictions to Mason-Pfizer monkey virus infection in New World monkey cells. J. Virol. 82, 11140-11151. (doi:10.1128/JVI.00269-08)
26. Stremlau M et al. 2006 Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5α restriction factor. Proc. Natl Acad. Sci. USA 103, 5514-5519. (doi:10.1073/pnas. 0509996103)
27. Yap MW, Mortuza GB, Taylor IA, Stoye JP. 2007 The design of artificial retroviral restriction factors. Virology 365, 302-314. (doi:10.1016/j.virol.2007.04.005)
28. Diaz-Griffero F, Qin X-R, Hayashi F, Kigawa T, Finzi A, Sarnak Z, Lienlaf M, Yokoyama S, Sodroski J. 2009 A B-box 2 surface patch important for TRIM5α self-association, capsid binding avidity and retrovirus restriction. J. Virol. 83, 10737-10751. (doi:10. 1128/JVI.01307-09)
29. Ganser-Pornillos BK, Chandrasekaran V, Pornillos O, Sodroski JG, Sundquist WI, Yeager M. 2011 Hexagonal assembly of a restricting TRIM5α protein. Proc. Natl Acad. Sci. USA 108, 534-539. (doi:10.1073/pnas.1013426108)
30. Song B, Gold B, O'hUigin C, Javanbakht M, Li X, Stremlau M, Winkler C, Dean M, Sodroski J. 2005 The B30.2(SPRY) domain of retroviral restriction factor TRIM5α exhibits lineage-specific length and sequence variation in primates. J. Virol. 79, 6111-6121. (doi:10.1128/JVI.79.10.6111-6121.2005)
31. Ohkura S, Yap MW, Sheldon T, Stoye JP. 2006 All three variable regions of the TRIM5α B30.2 domain can contribute to the specificity of retrovirus restriction. J. Virol. 80, 8554-8565. (doi:10.1128/ JVI.00688-06)
32. Sawyer SL, Wu LI, Emerman M, Malik HS. 2005 Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain. Proc. Natl Acad. Sci. USA 102, 2832-2837. (doi:10. 1073/pnas.0409853102)
33. Johnson WE, Sawyer SL. 2009 Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 61, 163-178. (doi:10.1007/ s00251-009-0358-y)
34. Fletcher AJ, Hue S, Schaller T, Pillay D, Towers GJ. 2010 Hare TRIM5α restricts divergent retroviruses and exhibits significant sequence variation from closely related lagomorpha TRIM5 genes. J. Virol. 84, 12463-12468. (doi:10.1128/JVI.01514-10)
35. de Matos AL, van der Loo W, Areal H, Lanning DK, Esteves PJ. 2011 Study of sylvilagus rabbit TRIM5αlpha species-specific domain: how ancient endoviruses could have shaped the antiviral repertoire in Lagomorpha. BMC Evol. Biol. 11, 294. (doi:10.1186/1471-2148-11-294)
36. Loewen N, Barraza R, Whitwam T, Saenz DT, Kemler I, Poeschla E. 2003 FUV vectors. Methods Mol. Biol. 229, 251-271.
37. Mitrophanous K, Yoon S, Rohll J, Patil D, Wilkes F, Kim V, Kingsman S, Kingsman A, Mazaratis N 1999 Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6, 1808-1818. (doi:10.1038/sj.gt.3301023)
38. Griffin SD, Allen JF, Lever AM. 2001 The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity. J. Virol. 75, 12058-12069. (doi:10.1128/JVI.75.24.12058-12069.2001)
39. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, Kingsman AJ. 1995 A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628-633. (doi:10.1093/nar/23.4.628)
40. Rahm N et al. 2011 Unique spectrum of activity of prosimian TRIM5α against exogenous and endogenous retroviruses. J. Virol. 85, 4173-4183. (doi:10.1128/JVI.00075-11)
41. Cutino-Moguel T, Fassati A. 2006 A phenotypic recessive, post-entry block in rabbit cells that results in aberrant trafficking of HIV-1. Traffic 7, 978-992. (doi:10.1111/j.1600-0854.2006.00449.x)
42. Yap MW, Nisole S, Stoye JP. 2005 A single amino acid change in the SPRY domain of human TRIM5α leads to HIV-1 restriction. Curr. Biol. 15, 73-78. (doi:10.1016/j.cub.2004.12.042)
43. Kozak CA, Chakraborti A. 1996 Single amino acid changes in the murine leukemia virus capsid protein gene define the target for Fv1 resistance. Virology 225, 300-306. (doi:10.1006/viro.1996.0604)
44. Li Y, Li X, Stremlau M, Lee M, Sodroski J. 2006 Removal of arginine 332 allows human TRIM5α to bind human immunodeficiency virus capsids and to restrict infection. J. Virol. 80, 6738-6744. (doi:10. 1128/JVI.00270-06)
45. Maillard PV, Reynard S, Serhan F, Turelli P, Trono D. 2007 Interfering residues narrow the spectrum of MLV restriction by human TRIM5αlpha. PLoS Pathog. 3, e200. (doi:10.1371/journal.ppat.0030200)
46. Newman RM et al. 2006 Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5α. Proc. Natl Acad. Sci. USA 103, 19134-19139. (doi:10.1073/pnas.0605838103)
47. Mortuza GB, Goldstone DC, Pashley C, Haire LF, Palmarini M, Taylor WR, Stoye JP, Taylor IA. 2009 Structure of the capsid amino-terminal domain from the betaretrovirus, Jaagsiekte sheep retrovirus. J. Mol. Biol. 386, 1179-1192. (doi:10.1016/j.jmb. 2008.10.066)
48. Li S, Hill CP, Sundquist WI, Finch JT. 2000 Image 11 reconstruction of helical assemblies of the HIV-1 CA protein. Nature 407, 409-413. (doi:10.1038/ 35030177)
49. Mortuza GB, Haire LF, Stevens A, Smerdon SJ, Stoye JP, Taylor IA. 2004 High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431, 481-485. (doi:10.1038/nature02915)
50. Ohkura S, Goldstone DC, Yap MW, Holden-Dye K, Taylor IA, Stoye JP. 2011 Novel escape mutants suggest an extensive TRIM5αlpha binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog. 7, e1002011. (doi:10.1371/journal.ppat.1002011)
51. Goldstone DC et al. 2013 A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral Matrix and Capsid. PLoS Pathog. 9, e1003376. (doi:10.1371/journal.ppat.1003376)
52. Meyerson NR, Sawyer SL. 2011 Two-stepping through time: mammals and viruses. Trends Microbiol. 19, 286-294. (doi:10.1016/j.tim.2011.03.006)
53. Kaiser SM, Malik HS, Emerman M. 2007 Restriction of an extinct retrovirus by the human TRIM5α antiviral protein. Science 316, 1756-1758. (doi:10. 1126/science.1140579)
54. Perez-Caballero D, Soll SJ, Bieniasz PD. 2008 Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5α proteins. PLoS Pathog. 4, e1000181. (doi:10.1371/ journal.ppat.1000181)
55. Luttge BG, Shehu-Xhilaga M, Demirov DG, Adamson CS, Soheilian F, Nagashima K, Stephen AG, Fisher RJ, Freed EO. 2008 Molecular characterization of feline immunodeficiency virus budding. J. Virol. 82, 2106-2119. (doi:10.1128/JVI.02337-07)
56. Gifford RJ, Katzourakis A, Tristem M, Pybus OG, Winters M, Shafer RW. 2008 A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc. Natl Acad. Sci. USA 105, 20362-20367. (doi:10.1073/pnas.0807873105)
57. Münk C, Brandt SM, Lucero G, Landau NR. 2002 A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl Acad. Sci. USA 99, 13843-13848. (doi:10.1073/pnas.212400099)
58. Hatziioannou T, Cowan S, von Schwedler UK, Sundquist WI, Bieniasz PD. 2004 Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J. Virol. 78, 6005-6012. (doi:10.1128/JVI.78.11.6005-6012.2004)
59. Kono K, Song H, Yokoyama M, Sato H, Shioda T, Nakayama EE. 2010 Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5αlpha-mediated restriction. Retrovirology 7, 72. (doi:10.1186/1742-4690-7-72)
60. Ylinen LMJ, Keckesova Z, Wilson SJ, Ranasinghe S, Towers GJ. 2005 Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5α alleles. J. Virol. 79, 11580-11587. (doi:10.1128/JVI.79.18. 11580-11587.2005)